Acta Scientific Pharmaceutical Sciences

Clinical ReviewVolume 2 Issue 2

First-Line Therapy in the Transplant Candidate Multiple Myeloma Patient: Short Clinical Review

Antonio Giovanni Solimando1*, Giuseppe Di Lernia1, Sebastiano Cicco1, Patrizia Leone1, Roberto Ria1, Vito Racanelli1, Christoph Köchel2, Daniel Gundel2, Angelo Vacca1 and Hermann Einsele2

1Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine “G. Baccelli”, University of Bari Medical School, Bari, Italy
2Medical Clinic and Polyclinic II, University Hospital Würzburg, Würzburg, Germany

*Corresponding Author: Antonio Giovanni Solimando, Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine “G. Baccelli”, University of Bari Medical School, Policlinico, Bari, Italy.

Received: December 29, 2017; Published: January 19, 2018

Citation: Antonio Giovanni Solimando., et al. “First-Line Therapy in the Transplant Candidate Multiple Myeloma Patient: Short Clinical Review”. Acta Scientific Pharmaceutical Sciences 2.2 (2018).

Abstract

  The current therapeutic paradigm for the transplant recipient in multiple myeloma needs to be continuously updated. It will be clarified if it actually defines the standard of care stating the unmet needs as well. With the dual purpose of treating a symptomatic disease and obtaining a maximized depth of response autologous stem cell support (ASCT) is the backbone of young multiple myeloma patient approach. This manuscript provides a real-life oriented strategy, needed for a patient centered clinical practice.

Keywords: Transplant; Multiple Myeloma; Autologous Stem Cell Support (ASCT)

Copyright: © 2018 Antonio Giovanni Solimando., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Member In



News and Events


  • Special Issue on Reviews
    Acta Scientific Journals has been started Special Issue on Reviews, researchers from world wide welcoming for submission of their reviews on any topic by on/ before August 30, 2019. Special Issue is going to be released on September 10, 2019
  • Submission Timeline for Regular Issue
    Last date for submission of articles is August 30, 2019.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US